Alamar Biosciences, Inc. (ALMR)

NASDAQ: ALMR · Real-Time Price · USD

27.11

+0.04 (0.15%)

At close: Aug 4, 2026, 4:00 PM EDT

27.89

+0.78 (2.89%)

After-hours: Aug 4, 2026, 4:26 PM EDT

Alamar Biosciences Employees

Alamar Biosciences had 222 employees as of December 31, 2025. The number of employees increased by 86 or 63.24% compared to the previous year.

Employees

222

Change (1Y)

86

Growth (1Y)

63.24%

Revenue / Employee

$392,590

Profits / Employee

-$195,878

Market Cap

1.88B

Employees Chart

Employees History

Date	Employees	Change (1Y)	Growth (1Y)
Dec 31, 2025	222	86	63.24%
Dec 31, 2024	136	-	-

Related Stocks

Company Name	Employees
AdaptHealth	10,900
Enovis	7,802
UFP Technologies	4,846
CONMED	3,900
Tandem Diabetes Care	2,500
Artivion	1,800
NovoCure	1,605
Inspire Medical Systems	1,333

Employee Rankings

ALMR News

7 days ago - Alamar Biosciences Launches NULISAseq™ Immune 340 Panel for Comprehensive Profiling of the Immune Proteome - GlobeNewsWire
20 days ago - Alamar Biosciences price target raised to $34 from $30 at TD Cowen - TheFly
21 days ago - Alamar Biosciences to Report Second Quarter 2026 Financial Results on August 10, 2026 - GlobeNewsWire
22 days ago - Alamar teams with research universities to launch proteomics initiatives - TheFly
22 days ago - Alamar Biosciences Partners with Leading Research Universities to Launch National Initiative Advancing Blood-Based Biomarkers for Neurodegenerative Diseases - GlobeNewsWire
25 days ago - Alamar Biosciences NULISA Data Featured in More Than 140 Scientific Presentations at AAIC 2026, Highlighting Advances in Blood-Based Alzheimer's Biomarker Profiling - GlobeNewsWire
4 weeks ago - Alamar Biosciences Launches the First Multiplexed Blood-based Immunoassay for eMTBR-Tau, One of the Most Important Biomarkers in Alzheimer's Disease Research - GlobeNewsWire
2 months ago - Alamar Biosciences Makes Home-Collected Fingerstick Samples Compatible with Ultra High-Sensitivity, Multiplex Proteomics - GlobeNewsWire